Tag Archive for: Angiogenesis

French biotech firm Massalia Therapeutics SA has been launched, backed by seed funding from Landmark Bioventures, the company founders and their network. The company claims to have an IND-ready, first-in-class drug candidate poised to target both cancer and fibrosis.

Angiogenesis, the growth of new blood vessels from pre-existing vasculature, is a normal process in growth and development, as well as in wound healing and tissue granulation.